FDA.reportPublic FDA data

Application 205217

Type
ANDA
Sponsor
LUPIN LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LAMIVUDINELAMIVUDINETABLET;ORAL150MGNoNo
002LAMIVUDINELAMIVUDINETABLET;ORAL300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68180-602LamivudineLamivudineLupin Pharmaceuticals, Inc.ANDACurrent
68180-602LamivudineLamivudineLupin Pharmaceuticals, Inc.ANDACurrent
68180-602LamivudineLamivudineLupin Pharmaceuticals, Inc.ANDACurrent
68180-603LamivudineLamivudineLupin Pharmaceuticals, Inc.ANDACurrent
68180-603LamivudineLamivudineLupin Pharmaceuticals, Inc.ANDACurrent
68180-603LamivudineLamivudineLupin Pharmaceuticals, Inc.ANDACurrent
70518-1933LamivudineLamivudineREMEDYREPACK INC.ANDACurrent
70518-1933LamivudineLamivudineREMEDYREPACK INC.ANDACurrent